Form 4 for PRVA Privia Health Group, Inc.
Accepted 2023-05-11 00:00:00 ET · period of report 2023-05-09 · accession 0001759655-23-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-09 | PRVA | Mountcastle David | EVP, CFO | A - Grant | $0.00 | +22.1K | 172.5K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2023-05-09 | A | A | 22,058 | $0.00 | 172,538 | D | — | — | (F1) On May 9, 2023, the reporting person received 22,058 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date. |